Marketresearchnews

Wednesday, 3 March 2021

Swollen Knee Treatment Market - Factors Driving Growth Post 2023

The global swollen knee treatment market is expected to register a significant growth during the forecast period (2018–2023).

Knee swelling or occasionally mentioned as “water on the knee” is a condition where excess fluid gets accumulated in an around the knee joint. This conditions in medical terms are referred to as “knee effusion”. The swollen knee can result due to injuries such as torn ligament, cartilage tear or broken bones. The increasing number of geriatric populations followed by the rising frequency of musculoskeletal diseases, a growing number of surgeries undertaken is projected to grow the global swollen knee treatment market. The operating procedure of knee replacement is inclusive of various steps taken to implant the artificial device and replacement of the damaged knee.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/6406

The swollen knee treatment market is anticipated to grow due to several factors such as the growing rate of elderly aged diseases like obesity, arthritis, osteoporosis, diabetes and sports-related injuries. Contrary, due to existing and upcoming advance technologies such as minimally invasive surgery and improved implant supplies are making it more broadly accepted even by the younger population.

In spite of being a widely used technique for curing extremely debilitating diseases, such as rheumatoid arthritis, the global swollen knee treatment market is confronting some challenges such as financial slowdown which is avoiding the growth of the market. Other growth restraining factors of the global swollen knee treatment market are intense competition, huge surgical cost, growing awareness for some non-surgical treatment methods such as exercises, shoe inserts, walking aids, weight loss programs, and painkiller medicines.

Segmentation

The global swollen knee treatment market has been segmented on the basis of type and end-users.

On the basis of type, the market has been classified as medications, patient-controlled analgesia (PCA) pumps, nerve blocks, liposomal bupivacaine, and surgery. The medications have been segmented into opioids and corticosteroids and others. The surgery is segmented into arthrocentesis, arthroscopy and knee replacement. The knee replacement is further segmented into total knee replacement, unicompartmental knee replacement, and others.

On the basis of end-users, the market has been classified as hospitals, clinics, ambulatory surgery centers, and others.

On the basis of region, the market is segmented into the Americas, Europe, Asia-Pacific, and the Middle East and Africa. The Americas has been further segmented into North America and South America, with the North American market divided into the US and Canada.

The European swollen knee treatment market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.

The swollen knee treatment market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The swollen knee treatment market in the Middle East and Africa has been segmented into the Middle East and Africa.

Regional Market Summary

In the swollen knee treatment market, North America is anticipated to account for the largest market share due to the early adoption of advanced medical technologies, the rise in awareness, the rise in growth of the healthcare sector, and due to favorable compensation setting for many surgical procedures.

The European market is expected to hold the second largest market share. The market growth in this region can be attributed to the rising frequency of diabetes patients, increasing number of surgeries, and increasing demand for advanced treatment procedures are boosting the European market.

The market share in Asia-Pacific is also projected to experience growth in the near future due to access to optimal treatment facilities and growing demand for advanced technology, better adoption rate, increase in disposable income, and rising medical tourism.

The market in the Middle East and Africa is expected to account for the smallest share of the global swollen knee treatment market due to an underdeveloped healthcare sector, lack of technical knowledge, and poor medical facilities.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/swollen-knee-treatment-market-6406

About Us:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Surgical Stapler 2020 Global Market Key Players, Analysis and Forecast to 2023

The Global Surgical Stapler Market is expected to grow during the forecast period (2018 to 2023) at a CAGR approx. 7.2 %.

A surgical stapler is a complex mechanical medical device that has been present in the market for years and is mature in technology. Surgical staplers are used in various surgeries such as gastrointestinal, gynecologic, thoracic, and many other surgeries to remove the part of organ and tissues. This surgical stapler reduces the time of surgical procedure. The global surgical stapler market is increasing due to increasing surgical procedures, the introduction of technologically advanced surgical staplers, and growing number of bariatric and other weight loss surgeries. However, due to increasing aesthetic surgeries, breast surgeries, surgical technology, and pediatric surgical procedures, the surgical stapler market size is expected to grow in the future.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/6382

However, the high cost of treatment, misuse of funding, and lack of awareness are some of the factors which are expected to hamper the growth of the market during the forecast period.

Segmentation

The global surgical stapler market is segmented into types, product, application, and end-users. Based on types the surgical stapler market is segmented into disposable surgical staplers and reusable surgical staplers. On the basis of the product, the market is segmented into manual surgical staplers and powered surgical staplers. Based on application, the surgical stapler market is segmented into abdominal and pelvic surgery, general surgery, cardiac and thoracic surgery, orthopedic surgery, and other surgical applications. Based on end-user the market is segmented into hospitals, ambulatory surgical centers (ASCs), and clinics.

Regional Market Summary

The market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East and Africa. The global surgical stapler market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada. The European global surgical stapler market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The global surgical stapler market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The surgical stapler market in the Middle East and Africa has been segmented into the Middle East and Africa.

North America will dominate the surgical stapler market during the forecast period. Technological advancements, growing geriatric population, and rising number of surgical procedures are likely to drive the surgical stapler market during the forecast period. North America and Europe are expected to hold a major share of around 70% of the surgical stapler market during the forecast period. The European market is expected to be the second-largest market. The market growth in this region can be attributed to the increasing awareness and adoption of the advanced surgical technology. Asia-Pacific is expected to be the fastest-growing surgical stapler market during the forecast period owing to the increasing prevalence of cardiac diseases, rising investments in healthcare, increasing geriatric population, and expansions by market players in the region. Asia-Pacific is giving strong competition to the global surgical stapler market by producing cost-effective treatments that are high in demand in local as well as global markets. The market in the Middle East and Africa is expected to account for the smallest share in the global surgical stapler market due to the underdeveloped healthcare sector, lack of technical knowledge, and poor medical facilities.

Key Players

Some of the key players in the global surgical stapler market are Ethicon. US, LLC., Cardica Inc, Smith and Nephew Plc, CONMED Corporation, Purple Surgical Inc., Welfare Medical Ltd, Reach Surgical, Grena Ltd, B.Braun Melsungen AG, Frankenman International Limited, Zimmer Biomet, Stryker, Meril Life Sciences Pvt. Ltd., Touchstone International Medical Science Co.Ltd, and Medtronic.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/surgical-stapler-market-6382

About Us:

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Kidney Dialysis Equipment Market Projected to Witness Vigorous Expansion by 2023

Every day, a healthy individual’s kidneys filter around 120 to 150 quarts of blood. If a person’s kidneys are not working efficiently, the waste gets accumulated in the blood. This may lead to coma and later death. Dialysis avoids the formation of waste products and toxins in the blood.

Dialysis machines are artificial kidneys used to filter patients’ blood during kidney damage, kidney dysfunction, kidney failure, and to remove excess impurities from kidneys. Dialysis machines use hemodialysis to purify the blood and balance the constituents. In this course, the patient’s blood is distributed through the machine which is filtered and well-adjusted for pH electrolytes and fluid concentration before sending it back to the patient’s body. Dialysis machines have extensive applications such as directing medical help to patients suffering from renal diseases.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/6302

Over the last decade, there had been many advances in renal dialysis equipment (both in portable and home dialysis machines), accessories, and consumables. According to the MRFR Research report, the global market for kidney dialysis equipment is likely to grow at a CAGR of 5.7% from an assessed USD 16.5 billion in 2017.

The development in this market is due to the rise in a number of End Stage Renal Disease Patients (ESRD), advanced technologies, and rise in cost-effective and accurate portable dialysis apparatus. The fast growth in the aging population, growing frequencies of diabetes and hypertension problems, and patients opting for dialysis treatments over kidney transplants due to lack of donors boost the market. Additionally, restrains for the market comprise the time consumption, risks and difficulties involved, and rules and regulations associated with dialysis.

Segmentation

The global kidney dialysis equipment market has been segmented on the basis of type, apparatus type, and end-user.

On the basis of type, the market has been classified as hemodialysis, peritoneal dialysis, and Continuous Renal Replacement Therapy (CRRT). Hemodialysis is segmented into conventional hemodialysis, short daily hemodialysis, and nocturnal hemodialysis. The peritoneal dialysis is segmented into Continuous Ambulatory Peritoneal Dialysis (CAPD), Continuous Cycling Peritoneal Dialysis (CCPD), Intermittent Peritoneal Dialysis (IPD), and Tidal Peritoneal Dialysis (TPD).

On the basis of apparatus type, the market has been classified into hemodialysis equipment, peritoneal dialysis equipment, and consumables and continuous renal replacement therapy systems. The hemodialysis equipment segment is categorized into hemodialysis machines, dialyzers and filters, bloodline systems, concentrates and solutions, tunneled hemodialysis catheters, and vascular access devices. The peritoneal dialysis equipment segment is categorized into concentrates and solutions, automated peritoneal dialysis machines, dialyzers, and filters.

On the basis of end-user, the market has been classified into hospitals, clinics, in-center dialysis settings, home care, and ambulatory services.

On the basis of region, the market is segmented into the Americas, Europe, Asia-Pacific, and the Middle East and Africa. The Americas has further been segmented into North America and South America, with the North American market is divided into the US and Canada.

The European kidney dialysis equipment market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.

The kidney dialysis equipment market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The kidney dialysis equipment market in the Middle East and Africa has been segmented into the Middle East and Africa.

Key Players

Some of the key players in the kidney dialysis equipment are Fresenius Medical Care AG & Co. Ka, Davita Healthcare Partners Inc., Baxter International Inc., B. Braun Melsungen AG, Diaverum Deutschland GmbH, Nipro Corporation, Nxstage Medical, Inc., Nikkiso Co., Ltd., Mar Cor Purification, Inc. (A Cantel Medical Company), Asahi Kasei Medical Co., Ltd. (A Subsidiary of Asahi Kasei Corporation). Terumo Corporation, Rockwell Medical, Teleflex Incorporated, and Hemoclean CO., LTD.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/kidney-dialysis-equipment-market-6302

About Us:

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Global Gastritis Treatment Market to Significant Growth Foreseen by 2023

The global artificial neural network market is expected to grow significantly over the forecast period. It is estimated that the global artificial neural network market is expected to grow significantly during the forecast period from 2018 to 2023.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/6287

An artificial neuron network is a computational model which resembles the function and structure of the human brain’s neuron system. The emergence of artificial intelligence and increasing adoption of the artificial neural network in the healthcare sector are the major drivers for the global artificial neural market. Factors such as the increasing healthcare expenditure, growing number of hospitalizations, and increasing prevalence of chronic diseases contribute to the growth of the market. Moreover, artificial neural networks provide significant benefits in medical research which is expected to fuel the market growth during the forecast period. Furthermore, owing to the growing adoption of artificial neuron network, many companies are engaged in developing artificial neuron network-based software. For instance, MAQ software by Microsoft implements an Artificial Neural Network (ANN) to learn from the historical data and predict the future values.

Despite the drivers, slow digitization across emerging economies and reluctance among healthcare professionals to adopt artificial intelligence-based technologies are likely to hamper the growth of the market during the assessment period.

Segmentation

The global artificial neural network market has been segmented into type, component, and application.

The market, on the basis of type, has been segmented into feedback artificial neural network, feedforward artificial neural network, and others.

The market, by component, has been segmented into software, services, and platform.

The global artificial neural network market, by application, has been segmented into clinical diagnosis and prognostics, image analysis and interpretation, bioelectric signal analysis and interpretation, drug development, and others.

The market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The artificial neural network market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada.

The European artificial neural network market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.

The artificial neural network market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The artificial neural network market in the Middle East & Africa has been segmented into the Middle East and Africa.

Key players

Neural Technologies Limited, SwiftKey, Starmind International AG, Afiniti, Ward Systems Group, Inc., SAP SE, NeuroDimension, Inc., Alyuda Research, LLC, Google Inc., Neuralware, Qualcomm Technologies, Inc., Intel Corporation, Microsoft Corporation, IBM Corporation, and Oracle Corporation are some of the key players in the global artificial neural network market.

Regional Market Summary

Geographically, the Americas is anticipated to dominate the global artificial neural network market owing to a well-developed healthcare sector, due to the presence of a large number of enterprises in the development of neural network technologies, and high adoption advanced technology in the healthcare sector. According to the Centers for Disease Control and Prevention, in 2015, the total national health expenditure was USD 3.2 trillion.

Europe is expected to hold the second largest position in the global artificial neural network market. The market growth in this region is attributed to the growing adoption of artificial intelligence among healthcare providers and increasing healthcare expenditure coupled with the rising prevalence of chronic diseases.

The Asia-Pacific region is expected to exhibit the fastest growth throughout the forecast period owing to the accelerated economic growth of countries in the region and the growing need to control the increasing healthcare costs. These factors are also responsible for the emerging trend towards the digitization of patient records among healthcare organizations in this region.

The Middle East & Africa has the least share of the global artificial neural network market. However, this region is expected to have a potential growth opportunity for the artificial neural network market during the forecast period. The key factors driving the growth rate in this region include increasing technological implementations and rising healthcare investments.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/artificial-neural-network-market-6287

About Us:

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Gastritis Treatment Market Plying for Significant Growth During 2020 - 2023

The inflammatory bowel disease treatment market is expected to register a CAGR of 2.5% during the forecast period. Inflammatory bowel disease is characterized by chronic inflammation of the digestive tract. It is an umbrella term for ulcerative colitis and Crohn’s disease. The market for inflammatory bowel disease treatment is growing worldwide due to factors such as the increasing prevalence of ulcerative colitis and Crohn’s disease, advances in medical technology, government support for inflammatory bowel disease treatment research, and the ubiquity of anxiety and depression. Moreover, increasing number of drugs in clinical trial and growing popularity of prebiotic and probiotic foods is likely to spur market growth. However, high capital investments required for drug discovery, unsatisfactory effectiveness of treatment, and stringent drug regulatory policies are restraining the growth of the inflammatory bowel disease treatment market.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/6266

Market Segmentation

The global inflammatory bowel disease treatment market has been segmented on the basis of drug class, disease indication, distribution channel, and end-user. Based on drug class, the market has been segmented into TNF inhibitors, aminosalicylates, immunomodulators, and corticosteroids.

By disease indication, the market has been segmented into ulcerative colitis and Crohn’s disease.

Based on distribution channel, the market has been segmented into hospital pharmacy, retail pharmacy, and online pharmacy.

By end-user, the market has been segmented into hospitals and clinics and others.

Based on region, the market has been segmented into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The market in the Americas has been further segmented into North America and South America. The European market has been further divided into Western Europe and Eastern Europe.

Regional Market Summary

Americas is expected to be the largest inflammatory bowel disease treatment market, by region. The increasing prevalence of anxiety and gluten allergies and inclination towards junk food has led to the increasing number of patients suffering from inflammatory bowel disease in the region. According to the Anxiety and Depression Association of America, anxiety was the most diagnosed mental disorder in the US, with around 40 million people, aged over 14, affected by anxiety every year. As per the Centers for Disease Control and Prevention (CDC), about 1.3% of US adults, approximately 3 million, were diagnosed with IBD, either Crohn’s disease or ulcerative colitis, in 2015. Furthermore, rising health awareness, the presence of key players, and established healthcare infrastructure are likely to enhance the growth of the inflammatory bowel disease treatment market in the region. According to the Centers for Medicare and Medicaid Services (CMS) in 2016, healthcare spending in the US increased by 4.3% to reach USD 3.3 trillion. Thus, increasing per capita income and rising healthcare spending will aid market growth in the Americas.

Europe was the second-largest inflammatory bowel disease treatment market, by region in 2017. The European market is expected to exhibit steady growth during the forecast period owing to the increasing prevalence of inflammatory bowel disease, rising rate of alcohol abuse, unhealthy lifestyle habits, and the increasing incidence of anxiety and depression among adults. Additionally, factors such as increasing government initiatives and funding for research, the development of advanced medical treatment options, and availability of favorable reimbursement policies are likely to propel the growth of the inflammatory bowel disease treatment market in Europe.

Asia-Pacific is expected to be the fastest-growing inflammatory bowel disease treatment market with an exponential rise in patient population. Japan and China are expected to be the largest markets for inflammatory bowel disease treatment in Asia-Pacific. The rising prevalence of anxiety and depression among adults as well as the increasing abuse of alcohol and sedentary lifestyles are expected to result in a growing patient pool, fueling the demand for treatment drugs. Furthermore, comparatively lenient drug regulatory policies and increasing government initiatives for healthcare reform are expected to propel market growth during the forecast period. Rising healthcare expenditure and rising standards of living in the region are also driving the growth of the inflammatory bowel disease treatment market in Asia-Pacific.

The market in the Middle East & Africa is expected to show the least growth due to a lack of awareness about the disease, limited access to and availability of treatment facilities, and lower prevalence of the disorder. However, the market may grow in the UAE, Kuwait, and Saudi Arabia.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/inflammatory-bowel-disease-treatment-market-6266

About Us:

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Gastritis Treatment Market Poised to Witness a Significant Growth by 2023

The gastritis treatment market is expected to exhibit a robust growth rate during the forecast period. Gastritis is characterized by a set of conditions that cause inflammation or irritation of the lining of the stomach, for a short or long time. Upper abdominal pain or discomfort is the most common symptom of Gastritis. Gastritis has been broadly categorized into three segments, namely, acute gastritis, chronic gastritis, and erosion of metaplasia or atrophic gastritis. The market for gastritis treatment is expanding worldwide due to drivers such as increasing occurrence of acute and chronic gastritis, advances in the area of medical technologies, increasing fast food chains worldwide, massive adoption of a sedentary lifestyle, and advancement in endoscopy devices that increased the accuracy of diagnosis. Moreover, chronic gastritis patients, rely on acidity reducing medicines for a lifetime, thus fueling the market demand which in turn would boost up the market growth. However, unaffordability and lack of advanced medical device technology in middle-income countries are likely to hamper the market growth.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/6230

Market Segmentation

The global gastritis treatment market is segmented on the basis of diagnosis, treatment type, drug distribution channel, and end-users.

Considering the diagnosis, the market is segmented into blood test, endoscopy, x-ray of the upper digestive system and others.

By treatment type, the market is segmented into acid-blocking medicines, antibiotics, antacids, and histamine blockers.

With reference to the drug distribution channel, the market is segmented into retail pharmacy, online pharmacy, and hospital pharmacy.

On account of end-users, the market is segmented hospitals & clinics and others.

Based on region the market is segmented into Americas, Europe, Asia-Pacific, and the Middle East and Africa. The American region is segmented into North America and South America. Similarly, Europe is segmented into Western Europe and Eastern Europe.

Regional Market Summary

The Americas is going to account for the largest share for gastritis treatment market. Drivers such as widespread of fast food chains in this region along with the increasing sedentary life culture which in turn contributes to increasing patient pool of gastritis and rising geriatric population are likely to enhance the growth of gastritis treatment market. Moreover, rising alcohol abuse, the presence of prominent key players is likely to spur the market growth. For instance, According to a published survey, approximately 1 in 100 is a victim of gastritis in the US. Thus, this increasing patient pool will enhance the market growth during the forecasted period. Additionally, factors such as increasing government initiatives and funding for research, development in advanced medical treatment options, and availability of favorable reimbursement policies are likely to propel the growth of gastritis treatment market in the American region. Furthermore, according to CMS (Centers for Medicare and Medicaid Services) US health care spending increased 4.3 percent to reach USD 3.3 trillion per person in 2016. Thus, the increasing per capita income of individuals, as well as rising healthcare spending, will aid up the market growth of the Americas.

Europe is the second market leader and holds a healthy share in the global gastritis treatment market. The European market is expected to exhibit a sturdy growth rate during the forecast period owing to the availability of advanced treatment facilities, established healthcare infrastructure along with the presence of a flourishing medical device market which helps in efficient and accurate diagnosis. Furthermore, due to the increasing number of lactose-intolerant issues, vulnerability to falling prey of gastritis is more likely to lead to an increasing number of gastritis sufferers. Thus, fueling the market growth during the forecast period.

Asia-Pacific is expected to be the fastest emerging market owing to increasing government initiatives for healthcare reform, increasing adaption of a sedentary lifestyle, and increasing prevalence of gastritis. Moreover, the prevalence of multifocal atrophic gastritis and gastric adenocarcinomas is high in these regions. Furthermore, the presence of renowned domestic pharmaceutical players, as well as the increasing healthcare spending per capita, is going to accelerate the market growth during the forecast period.

The Middle East & Africa is expected to show the least growth in the market due to some major factors such as lack of awareness, limited access and availability of treatment facilities. In the Middle East, the United Arab Emirates is the largest market share owing to the development of healthcare industry and rising availability of specialty care centers. With an increasing number of gastrointestinal disorders region in this region, many key players are willing to set up their research and development centers to find a cure for these diseases. Moreover, the government is aiming at improving the healthcare infrastructure. Thus, a steady growth rate might be seen during the forecast period.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/gastritis-treatment-market-6230

About Us:

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

APAC Pregnancy & Ovulation Testing 2020 Global Market Key Players, Analysis and Forecast to 2023

The Asia Pacific pregnancy and ovulation testing market is anticipated to touch USD 298.68 billion by 2023, as per an insightful report by Market Research Future (MRFR). It is expected to exhibit a 6.1% CAGR during the assessment period (2018-2023). The increasing acceptance of home testing kits to check the possibility of pregnancy is projected to spur market demand during the forecast period.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/6198

Pregnancy tests are kits capable of detecting hormones such as human chorionic gonadotropin (hCG) in urine. Ovulation tests, on the other hand, are capable of detecting an uptick in luteinizing hormone (LH) to decide the optimal time for conceiving children. Availability of ovulation monitors on e-commerce websites, awareness of fertility tests, and awareness of these tests made possible by various promotional marketing activities by major brands are likely to lead to an uptick in market demand over the forecast period.

Digitization of results to provide privacy to consumers has been made possible owing to pervasiveness of smartphones. For instance, the FIRST RESPONSE Pregnancy PRO Digital Test & App Access by Church & Dwight Co., sends accurate results to the consumer’s smartphone. But high costs of ovulation tests can act as a market deterrent.

Report Overview

This report allows the user to gain a deeper understanding of the ongoing events and trends in the Asia Pacific (APAC) market for pregnancy and ovulation testing. By correlating the historical data with key market dynamics, our analysts can make highly accurate projections in the report. MRFR’s report includes a thorough segmental analysis of the APAC market segmented by type, mode of purchase, end-user, and region with astute insights. This report has been prepared to assist industry participants in making informed decisions on growth strategies and operation management. Users will come across drivers, trends, opportunities, and restraints which are likely to influence the growth of the market during the assessment period.

Segment Overview

By type, the Asia Pacific pregnancy and ovulation testing market has been segmented into pregnancy and ovulation testing. The pregnancy testing segment is sub-segmented into blood-based and urine-based testing. This segment is touted to garner above average demand owing to advances in pregnancy testing kits and alarming cases of polycystic ovary syndrome (PCOS). Similarly, the ovulation testing segment is sub-segmented into fertility monitors and ovulation prediction kits.

By mode of purchase, the market is segmented into prescription and non-prescription testing/over-the-counter (OTC) testing. The non-prescription testing mode of purchase is projected to experience remarkable growth thanks to preference for home pregnancy tests and privacy concerns among women.

By end-user, the market is segmented into fertility centers, hospitals and clinics, and others. The hospitals and clinics segment is likely to register a 5.8% CAGR during the forecast period owing to their propensity to handle large patient volumes.

The segments and sub-segments covered in the report are analyzed under six major regions – India, China, Japan, Republic of Korea, Australia, and Rest of Asia Pacific, with respective country-level market sizing. For the scope of research, the standard definition of the product/service “pregnancy and ovulation testing” is included in the report. The report discusses and interprets the current and future opportunities of the industry by delivering an unbiased growth assessment.

Players Covered

Gregory Pharmaceutical Holdings, Inc., Proctor & Gamble, TaiDoc Technology & Corporation, Mankind Pharma Ltd., Geratherm Medical AG, Fairhaven Health, LLC, Quidel Corporation, Piramal Enterprises Ltd., Cadila Healthcare Limited, and Church & Dwight Co., Inc., are noteworthy players in the Asia Pacific pregnancy and ovulation testing market.

The report offers comprehensive profiles on these market players and assesses their current standing in the Asia Pacific pregnancy and ovulation testing market. Company history coupled with annual turnover, segmental share, SWOT analysis, growth strategies, new product launches, mergers and acquisitions (M&A) activities, and latest R&D initiatives are outlined in the report.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/asia-pacific-pregnancy-ovulation-testing-market-6198

About Us:

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com